Precision Vascular ships Synchro neurovascular line:
This article was originally published in Clinica
Executive Summary
Precision Vascular has begun shipping its Synchro line of neurovascular guidewires to key neurovascular centres in Europe and the US. The technology combines microfabrication techniques with advanced superelastic materials for the delivery of devices to treat conditions such as aneurysms, arteriovenous malformations and strokes. The company, of West Valley City, Utah, plans to apply the microfabrication technology to additional guidewire and catheter-based designs.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.